Gene · 70
Papers1,745
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 1,745
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| OpenCell: Endogenous tagging for the cartography of human cellular organization. | Science | 2022 | 35271311 | PubTator, text mining | PubMed |
| Cardiac Tissue-like 3D Microenvironment Enhances Route towards Human Fibroblast Direct Reprogramming into Induced Cardiomyocytes by microRNAs. | Cells | 2022 | 35269422 | PubTator, text mining | PubMed |
| The Role of GJD2(Cx36) in Refractive Error Development. | Invest Ophthalmol Vis Sci | 2022 | 35262731 | PubTator, text mining | PubMed |
| Histone deacetylase inhibitors inhibit cervical cancer growth through Parkin acetylation-mediated mitophagy. | Acta Pharm Sin B | 2022 | 35256949 | PubTator, text mining | PubMed |
| Genetic resiliency associated with dominant lethal TPM1 mutation causing atrial septal defect with high heritability. | Cell Rep Med | 2022 | 35243414 | PubTator, text mining | PubMed |
| A master autoantigen-ome links alternative splicing, female predilection, and COVID-19 to autoimmune diseases. | J Transl Autoimmun | 2022 | 35237749 | PubTator, text mining | PubMed |
| Critical Evaluation of Current Hypotheses for the Pathogenesis of Hypertrophic Cardiomyopathy. | Int J Mol Sci | 2022 | 35216312 | PubTator, text mining | PubMed |
| Transcriptomic Signatures of End-Stage Human Dilated Cardiomyopathy Hearts with and without Left Ventricular Assist Device Support. | Int J Mol Sci | 2022 | 35216165 | PubTator, text mining | PubMed |
| Discerning the Ambiguous Role of Missense TTN Variants in Inherited Arrhythmogenic Syndromes. | J Pers Med | 2022 | 35207729 | PubTator, text mining | PubMed |
| Left and Right Ventricular Morphology, Function and Myocardial Deformation in Children with Left Ventricular Non-Compaction Cardiomyopathy: A Case-Control Cardiovascular Magnetic Resonance Study. | J Clin Med | 2022 | 35207378 | PubTator, text mining | PubMed |
| Cell and Tissue Nanomechanics: From Early Development to Carcinogenesis. | Biomedicines | 2022 | 35203554 | PubTator, text mining | PubMed |
| ASF1B: A Possible Prognostic Marker, Therapeutic Target, and Predictor of Immunotherapy in Male Thyroid Carcinoma. | Front Oncol | 2022 | 35174076 | PubTator, text mining | PubMed |
Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry. | Eur Heart J Qual Care Clin Outcomes | 2022 | 35138368 | PubTator, text mining | PubMed |
| Role of genetic testing in cardiomyopathies: Α primer for cardiologists. | World J Cardiol | 2022 | 35126870 | PubTator, text mining | PubMed |
| Cardiac stem cells: Current knowledge and future prospects. | World J Stem Cells | 2022 | 35126826 | PubTator, text mining | PubMed |
| Subclinical Hypertrophic Cardiomyopathy in Elite Athletes: Knowledge Gaps Persist. | JACC Case Rep | 2022 | 35106492 | PubTator, text mining | PubMed |
| Numb and Numblike regulate sarcomere assembly and maintenance. | J Clin Invest | 2022 | 35104799 | PubTator, text mining | PubMed |
| Identification of heart failure with preserved ejection fraction helps risk stratification for hypertrophic cardiomyopathy. | BMC Med | 2022 | 35078475 | PubTator, text mining | PubMed |
| Secretome of Stressed Peripheral Blood Mononuclear Cells Alters Transcriptome Signature in Heart, Liver, and Spleen after an Experimental Acute Myocardial Infarction: An In Silico Analysis. | Biology (Basel) | 2022 | 35053121 | PubTator, text mining | PubMed |
| SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids. | Cell Stem Cell | 2022 | 35032430 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/70/papers?page=25